HopeStage
Back to all studies
CompletedNCT02185131

Mirtazapine Compared With Placebo for Depression and Alcohol Use

About this titleRead the official source — NCT02185131
Medication studyAges 18–55United States
The study in practice

Understand this study

Who was this study for?

Listed age limits: 18 years to 55 years.

Listed locations
PittsburghSee all locations and recruitment
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateSeptember 2013
Recruitment status
Completed
Enrollment listed in the registry
16
Sponsor
University of Pittsburgh
Sponsor type
University
Study type
Drug
Intervention type
Drug
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Locations
United States
Age range
From 18 Years to 55 Years
Official registry ID
NCT02185131
Official title
Show the full official title

Double-blind Pilot Trial of Mirtazapine for the Treatment of Co-occurring AD/MDD.

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Pittsburgh

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is University of Pittsburgh, a university.

Did this study involve medication?

Yes. The study involved medication, including Mirtazapine and Placebo.

Who was this study for?

Listed age limits: 18 years to 55 years.

Want to explore more studies?

Explore studies